A natural supplement containing D-mannose, probiotics, and plant extracts reduced recurring urinary tract infections by about 85% over 6 months, matching the effectiveness of a low-dose antibiotic in a 2026 study of 89 women. According to Gram Research analysis, the supplement group experienced zero side effects while both treatments similarly improved quality of life, suggesting women with recurring UTIs may have an effective antibiotic-free prevention option worth discussing with their doctor.
A new study compared a natural supplement containing five ingredients to an antibiotic commonly used to prevent recurring urinary tract infections in women. According to Gram Research analysis, both treatments worked similarly well over six months, reducing UTI episodes by about 85%. The supplement group experienced no side effects, while both groups reported improved quality of life. This research suggests that women with recurring UTIs may have an effective alternative to antibiotics, which is important as antibiotic resistance becomes a growing health concern worldwide.
Key Statistics
A 2026 comparative study of 89 women found that a natural supplement reduced recurrent UTI episodes from an average of 1.87 per person to 0.28 per person over 6 months—an 85% reduction—matching the effectiveness of low-dose Fosfomycin antibiotic therapy.
In a 2026 study of 55 women taking a multi-ingredient supplement for recurrent UTIs, zero side effects were reported over the 6-month treatment period, compared to typical antibiotic use which commonly causes digestive upset and other adverse reactions.
A 2026 preliminary study found that both a natural supplement and antibiotic therapy similarly improved quality of life in women with recurrent UTIs, with infection rates dropping from approximately 2 episodes per person at baseline to less than 0.3 episodes by 6 months.
Research reviewed by Gram in 2026 showed that a supplement containing D-mannose, Lactobacillus rhamnosus, and Hibiscus extract reduced UTI recurrence in 55 women to levels comparable with Fosfomycin antibiotic treatment, suggesting a potential non-antibiotic prevention strategy.
The Quick Take
- What they studied: Whether a natural supplement with five ingredients could prevent recurring urinary tract infections as effectively as a low-dose antibiotic called Fosfomycin
- Who participated: 89 women with a history of repeated UTIs: 55 took the natural supplement and 34 took the antibiotic. The supplement group averaged 62 years old with an average BMI of 27
- Key finding: Both treatments reduced UTI episodes dramatically—from about 2 infections per person at the start to less than 1 per person after 6 months, with the supplement group showing no side effects
- What it means for you: Women who get repeated UTIs may have a natural alternative to antibiotics that works just as well without side effects, though more research with larger groups is needed before making treatment decisions
The Research Details
This was a comparative observational study, meaning researchers followed two groups of women with recurring UTIs and compared their outcomes without randomly assigning them to treatments. One group took a natural supplement containing D-mannose, Palmitoylethanolamide, N-acetylcysteine, Lactobacillus rhamnosus, and Hibiscus extract for 14 days each month over 6 months. The other group received low-dose Fosfomycin (an antibiotic) every 10 days for the same period.
Researchers checked both groups at 3 months and 6 months to count how many UTIs occurred, test urine samples, and measure quality of life using questionnaires. They also asked patients about side effects and satisfaction with their treatment. This design allowed direct comparison of real-world outcomes between the two approaches.
This research approach is important because it tests treatments in conditions closer to how they’re actually used in medical practice, rather than in a controlled laboratory setting. By tracking the same patients over time and measuring multiple outcomes—not just infection rates but also quality of life and side effects—the study provides a fuller picture of how each treatment affects women’s daily lives. This matters especially for recurring UTIs, where preventing infections and maintaining good quality of life are equally important goals.
This study has some important limitations to understand: it’s relatively small (89 total participants), and it’s observational rather than randomized, meaning the groups weren’t randomly assigned and may have had different characteristics. The supplement group was larger than the antibiotic group, which could affect comparisons. However, the study did include proper medical evaluations at set time points and used standardized quality-of-life questionnaires, which strengthens the reliability of those measurements.
What the Results Show
The supplement group started with an average of 1.87 UTI episodes per person over the study period. After 3 months, this dropped to 0.51 episodes, and by 6 months, it fell to just 0.28 episodes—a reduction of about 85%. The Fosfomycin group showed similar improvements, with both groups achieving comparable infection rates by the end of the study.
Quality of life improved in both groups, meaning women reported feeling better and experiencing less disruption to their daily activities. Importantly, the supplement group reported zero side effects throughout the entire 6-month period. This is significant because antibiotics can cause digestive problems, allergic reactions, and other unwanted effects in some people.
However, patient satisfaction told a different story. While both groups improved clinically, satisfaction scores actually declined in both groups by the end of the study, with the Fosfomycin group showing lower overall satisfaction. This suggests that even though infections decreased, patients may have had concerns about other aspects of their treatment experience.
The study found that both treatments were well-tolerated in terms of completing the full 6-month course. Microbiological testing (examining urine samples under a microscope) confirmed the clinical improvements in infection rates. The supplement’s multiple ingredients—including D-mannose (a natural sugar that may prevent bacteria from sticking to bladder walls), probiotics (beneficial bacteria), and plant extracts—appeared to work together effectively. The fact that no side effects occurred in the supplement group contrasts with typical antibiotic use, where some patients experience digestive upset or other reactions.
This research adds to growing evidence that natural approaches may help prevent recurring UTIs. Previous studies have suggested that D-mannose and probiotics individually may reduce UTI recurrence, but this appears to be one of the first studies comparing a multi-ingredient supplement directly to antibiotic therapy. The similar effectiveness to Fosfomycin is noteworthy because it suggests that non-antibiotic options deserve serious consideration, especially given rising concerns about antibiotic resistance. However, this single study is preliminary and needs confirmation with larger, more rigorous trials before changing standard treatment recommendations.
The study’s main limitations include its small size (89 participants total), which means results may not apply to all women with recurring UTIs. The groups weren’t randomly assigned, so we can’t be completely certain the supplement and antibiotic groups were comparable at the start. The supplement group was larger (55 vs. 34), which could skew comparisons. The study was observational rather than a gold-standard randomized controlled trial, meaning other factors we didn’t measure could have influenced results. Additionally, the declining satisfaction scores in both groups raise questions about what aspects of treatment bothered patients, which the study didn’t fully explore. Finally, this is preliminary research from 2026, and longer follow-up would help determine if benefits persist beyond 6 months.
The Bottom Line
For women with recurring UTIs, this research suggests a natural supplement containing D-mannose, probiotics, and plant extracts may be worth discussing with a healthcare provider as a potential alternative to antibiotics—particularly for those concerned about antibiotic side effects or resistance. However, this is preliminary evidence (moderate confidence level), and the decision should be made with medical guidance. Women should not stop prescribed antibiotics without consulting their doctor. The supplement approach may be most appropriate for prevention between infections rather than treating active infections.
This research is most relevant for women who experience 2 or more UTIs per year and want to explore non-antibiotic prevention options. It may be particularly interesting for those who experience side effects from antibiotics or who are concerned about antibiotic resistance. Healthcare providers treating recurrent UTIs should be aware of this evidence. However, women with severe or complicated UTIs, pregnant women, and those with kidney disease should continue following their doctor’s recommendations, as this supplement hasn’t been tested in these populations.
Based on this study, women taking the supplement showed significant improvement within 3 months, with further improvement by 6 months. Realistic expectations would be to see reduced infection frequency within the first 3 months of consistent use, though individual results will vary. The study only followed patients for 6 months, so it’s unclear if benefits continue beyond that timeframe or if the supplement needs to be taken indefinitely.
Frequently Asked Questions
Can I use a natural supplement instead of antibiotics for recurring UTIs?
A 2026 study found a natural supplement reduced recurring UTIs by 85% over 6 months, matching antibiotic effectiveness with zero side effects. However, this is preliminary research. Discuss with your doctor before stopping antibiotics, as treatment decisions depend on your individual situation and infection severity.
What ingredients in the supplement help prevent urinary tract infections?
The study tested a supplement containing D-mannose (a natural sugar that prevents bacteria from sticking to bladder walls), Lactobacillus rhamnosus (beneficial bacteria), N-acetylcysteine, Palmitoylethanolamide, and Hibiscus extract. These ingredients work together to reduce infection risk, though individual ingredient effectiveness wasn’t separately measured.
How long does it take to see improvement with the supplement?
In the 2026 study, women taking the supplement showed significant improvement within 3 months, with further reduction in infections by 6 months. Individual results vary, so discuss realistic timelines with your healthcare provider before starting.
Is this supplement safe to take long-term?
The study found no side effects over 6 months, which is promising. However, this research only tracked safety for 6 months, so long-term safety beyond that period hasn’t been established. Consult your doctor about extended use and whether this supplement is appropriate for your health situation.
Who should not use this supplement for UTI prevention?
This study didn’t test the supplement in pregnant women, people with kidney disease, or those with severe UTIs. These groups should follow their doctor’s recommendations rather than self-treating with supplements. Anyone with allergies to the ingredients should also avoid it.
Want to Apply This Research?
- Track UTI episodes monthly by logging symptoms (urgency, burning, frequency) and any confirmed infections. Record supplement adherence (days taken each month) alongside infection occurrences to identify patterns between consistent use and infection prevention.
- Set a monthly reminder to take the supplement for 14 consecutive days each month as tested in the study. Log daily water intake (aim for 8+ glasses) and bathroom habits, as hydration supports UTI prevention alongside supplement use.
- Create a 6-month tracking dashboard showing: (1) monthly UTI episode count, (2) supplement adherence percentage, (3) symptom severity scores, and (4) quality-of-life ratings. Compare your personal trends to the study’s baseline-to-6-month improvement pattern to assess whether the supplement is working for your individual situation.
This research is preliminary (published 2026) and based on a small study of 89 women. It has not undergone the rigorous testing required for FDA approval or standard medical recommendations. Do not use this information to replace medical advice from your healthcare provider. Women with active UTI symptoms, pregnant women, those with kidney disease, or anyone taking medications should consult their doctor before starting any supplement. This supplement is not intended to treat acute UTI infections—only to help prevent recurrence. Always discuss any new treatment approach with your healthcare provider before making changes to your current care plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.